DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Two VHH Antibodies Neutralize Botulinum Neurotoxin E1 by Blocking Its Membrane Translocation in Host Cells

Abstract

Botulinum neurotoxin serotype E (BoNT/E) is one of the major causes of human botulism, which is a life-threatening disease caused by flaccid paralysis of muscles. After receptor-mediated toxin internalization into motor neurons, the translocation domain (HN) of BoNT/E transforms into a protein channel upon vesicle acidification in endosomes and delivers its protease domain (LC) across membrane to enter the neuronal cytosol. It is believed that the rapid onset of BoNT/E intoxication compared to other BoNT serotypes is related to its swift internalization and translocation. We recently identified two neutralizing single-domain camelid antibodies (VHHs) against BoNT/E1 termed JLE-E5 and JLE-E9. Here, we report the crystal structures of these two VHHs bound to the LCHN domain of BoNT/E1. The structures reveal that these VHHs recognize two distinct epitopes that are partially overlapping with the putative transmembrane regions on HN, and therefore could physically block membrane association of BoNT/E1. This is confirmed by our in vitro studies, which show that these VHHs inhibit the structural change of BoNT/E1 at acidic pH and interfere with BoNT/E1 association with lipid vesicles. Therefore, these two VHHs neutralize BoNT/E1 by preventing the transmembrane delivery of LC. Furthermore, structure-based sequence analyses show that the 3-dimensional epitopes of thesemore » two VHHs are largely conserved across many BoNT/E subtypes, suggesting a broad-spectrum protection against the BoNT/E family. In summary, this work improves our understanding of the membrane translocation mechanism of BoNT/E and paves the way for developing VHHs as diagnostics or therapeutics for the treatment of BoNT/E intoxication.« less

Authors:
 [1]; ORCiD logo [2]; ORCiD logo [3]; ORCiD logo [1]
  1. Univ. of California, Irvine, CA (United States)
  2. Cornell Univ., Ithaca, NY (United States); Argonne National Lab. (ANL), Argonne, IL (United States)
  3. Tufts Univ., North Grafton, MA (United States)
Publication Date:
Research Org.:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Org.:
USDOE; National Institutes of Health (NIH); National Institute of Allergy and Infections Diseases (NIAID)
OSTI Identifier:
1673777
Grant/Contract Number:  
R01AI139087; R21AI139690; R21AI123920; R01AI125704; P30 GM124165; S10OD021527; AC02-06CH11357
Resource Type:
Accepted Manuscript
Journal Name:
Toxins
Additional Journal Information:
Journal Volume: 12; Journal Issue: 10; Journal ID: ISSN 2072-6651
Publisher:
MDPI
Country of Publication:
United States
Language:
ENGLISH
Subject:
60 APPLIED LIFE SCIENCES; botulinum neurotoxin; botulism; single-domain antibody; VHH; neutralizing epitope; antitoxin; membrane translocation

Citation Formats

Lam, Kwok-Ho, Perry, Kay, Shoemaker, Charles B., and Jin, Rongsheng. Two VHH Antibodies Neutralize Botulinum Neurotoxin E1 by Blocking Its Membrane Translocation in Host Cells. United States: N. p., 2020. Web. doi:10.3390/toxins12100616.
Lam, Kwok-Ho, Perry, Kay, Shoemaker, Charles B., & Jin, Rongsheng. Two VHH Antibodies Neutralize Botulinum Neurotoxin E1 by Blocking Its Membrane Translocation in Host Cells. United States. https://doi.org/10.3390/toxins12100616
Lam, Kwok-Ho, Perry, Kay, Shoemaker, Charles B., and Jin, Rongsheng. Sun . "Two VHH Antibodies Neutralize Botulinum Neurotoxin E1 by Blocking Its Membrane Translocation in Host Cells". United States. https://doi.org/10.3390/toxins12100616. https://www.osti.gov/servlets/purl/1673777.
@article{osti_1673777,
title = {Two VHH Antibodies Neutralize Botulinum Neurotoxin E1 by Blocking Its Membrane Translocation in Host Cells},
author = {Lam, Kwok-Ho and Perry, Kay and Shoemaker, Charles B. and Jin, Rongsheng},
abstractNote = {Botulinum neurotoxin serotype E (BoNT/E) is one of the major causes of human botulism, which is a life-threatening disease caused by flaccid paralysis of muscles. After receptor-mediated toxin internalization into motor neurons, the translocation domain (HN) of BoNT/E transforms into a protein channel upon vesicle acidification in endosomes and delivers its protease domain (LC) across membrane to enter the neuronal cytosol. It is believed that the rapid onset of BoNT/E intoxication compared to other BoNT serotypes is related to its swift internalization and translocation. We recently identified two neutralizing single-domain camelid antibodies (VHHs) against BoNT/E1 termed JLE-E5 and JLE-E9. Here, we report the crystal structures of these two VHHs bound to the LCHN domain of BoNT/E1. The structures reveal that these VHHs recognize two distinct epitopes that are partially overlapping with the putative transmembrane regions on HN, and therefore could physically block membrane association of BoNT/E1. This is confirmed by our in vitro studies, which show that these VHHs inhibit the structural change of BoNT/E1 at acidic pH and interfere with BoNT/E1 association with lipid vesicles. Therefore, these two VHHs neutralize BoNT/E1 by preventing the transmembrane delivery of LC. Furthermore, structure-based sequence analyses show that the 3-dimensional epitopes of these two VHHs are largely conserved across many BoNT/E subtypes, suggesting a broad-spectrum protection against the BoNT/E family. In summary, this work improves our understanding of the membrane translocation mechanism of BoNT/E and paves the way for developing VHHs as diagnostics or therapeutics for the treatment of BoNT/E intoxication.},
doi = {10.3390/toxins12100616},
journal = {Toxins},
number = 10,
volume = 12,
place = {United States},
year = {Sun Sep 27 00:00:00 EDT 2020},
month = {Sun Sep 27 00:00:00 EDT 2020}
}

Works referenced in this record:

Camelid Single-Domain Antibodies: Historical Perspective and Future Outlook
journal, November 2017


Overview of the CCP 4 suite and current developments
journal, March 2011

  • Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 67, Issue 4
  • DOI: 10.1107/S0907444910045749

Formation of ion channels in lipid bilayers by a peptide with the predicted transmembrane sequence of botulinum neurotoxin A
journal, August 1995

  • Oblatt-Montal, Myrta; Yamazaki, Masahito; Nelson, Richard
  • Protein Science, Vol. 4, Issue 8
  • DOI: 10.1002/pro.5560040806

Identification and characterization of a novel botulinum neurotoxin
journal, August 2017

  • Zhang, Sicai; Masuyer, Geoffrey; Zhang, Jie
  • Nature Communications, Vol. 8, Issue 1
  • DOI: 10.1038/ncomms14130

Diverse binding modes, same goal: The receptor recognition mechanism of botulinum neurotoxin
journal, March 2015


A Single-Domain Llama Antibody Potently Inhibits the Enzymatic Activity of Botulinum Neurotoxin by Binding to the Non-Catalytic α-Exosite Binding Region
journal, April 2010

  • Dong, Jianbo; Thompson, Aaron A.; Fan, Yongfeng
  • Journal of Molecular Biology, Vol. 397, Issue 4
  • DOI: 10.1016/j.jmb.2010.01.070

Domain Organization in Clostridium botulinum Neurotoxin Type E Is Unique: Its Implication in Faster Translocation
journal, February 2009

  • Kumaran, Desigan; Eswaramoorthy, Subramaniam; Furey, William
  • Journal of Molecular Biology, Vol. 386, Issue 1
  • DOI: 10.1016/j.jmb.2008.12.027

Botulinum Neurotoxin Heavy Chain Belt as an Intramolecular Chaperone for the Light Chain
journal, January 2007


Botulinum Neurotoxins B and E Translocate at Different Rates and Exhibit Divergent Responses to GT1b and Low pH
journal, July 2012

  • Sun, Shihu; Tepp, William H.; Johnson, Eric A.
  • Biochemistry, Vol. 51, Issue 28
  • DOI: 10.1021/bi3004928

Neutralisation of specific surface carboxylates speeds up translocation of botulinum neurotoxin type B enzymatic domain
journal, October 2013


Camelid nanobodies: killing two birds with one stone
journal, June 2015

  • Desmyter, Aline; Spinelli, Silvia; Roussel, Alain
  • Current Opinion in Structural Biology, Vol. 32
  • DOI: 10.1016/j.sbi.2015.01.001

Novel Chimeras of Botulinum Neurotoxins A and E Unveil Contributions from the Binding, Translocation, and Protease Domains to Their Functional Characteristics
journal, April 2008

  • Wang, Jiafu; Meng, Jianghui; Lawrence, Gary W.
  • Journal of Biological Chemistry, Vol. 283, Issue 25
  • DOI: 10.1074/jbc.M710442200

First Case of Type E Wound Botulism Diagnosed Using Real-Time PCR
journal, September 2007

  • Artin, I.; Bjorkman, P.; Cronqvist, J.
  • Journal of Clinical Microbiology, Vol. 45, Issue 11
  • DOI: 10.1128/JCM.01192-07

Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin
journal, December 2006

  • Garcia-Rodriguez, Consuelo; Levy, Raphael; Arndt, Joseph W.
  • Nature Biotechnology, Vol. 25, Issue 1
  • DOI: 10.1038/nbt1269

Targeting botulinum neurotoxin persistence by the ubiquitin-proteasome system
journal, September 2010

  • Tsai, Y. C.; Maditz, R.; Kuo, C. -l.
  • Proceedings of the National Academy of Sciences, Vol. 107, Issue 38
  • DOI: 10.1073/pnas.1008302107

Single molecule detection of intermediates during botulinum neurotoxin translocation across membranes
journal, June 2007

  • Fischer, A.; Montal, M.
  • Proceedings of the National Academy of Sciences, Vol. 104, Issue 25
  • DOI: 10.1073/pnas.0700046104

Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature
journal, January 2017


The Therapeutic Potential of Nanobodies
journal, November 2019


Botulinum neurotoxins: genetic, structural and mechanistic insights
journal, June 2014

  • Rossetto, Ornella; Pirazzini, Marco; Montecucco, Cesare
  • Nature Reviews Microbiology, Vol. 12, Issue 8
  • DOI: 10.1038/nrmicro3295

Tables of Toxicity of Botulinum and Tetanus Neurotoxins
journal, November 2019


Variations in the Botulinum Neurotoxin Binding Domain and the Potential for Novel Therapeutics
journal, October 2018


Inference of Macromolecular Assemblies from Crystalline State
journal, September 2007


XDS
journal, January 2010

  • Kabsch, Wolfgang
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2
  • DOI: 10.1107/S0907444909047337

Molecular Architecture of Botulinum Neurotoxin E Revealed by Single Particle Electron Microscopy
journal, November 2007

  • Fischer, Audrey; Garcia-Rodriguez, Consuelo; Geren, Isin
  • Journal of Biological Chemistry, Vol. 283, Issue 7
  • DOI: 10.1074/jbc.M707917200

Crystal Structures of Botulinum Neurotoxin DC in Complex with Its Protein Receptors Synaptotagmin I and II
journal, September 2013

  • Berntsson, Ronnie Per-Arne; Peng, Lisheng; Svensson, Linda Marie
  • Structure, Vol. 21, Issue 9
  • DOI: 10.1016/j.str.2013.06.026

Structural Insights into Rational Design of Single-Domain Antibody-Based Antitoxins against Botulinum Neurotoxins
journal, February 2020


A Three Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotype E Subtypes
journal, March 2018


Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
journal, November 2017


A camelid single-domain antibody neutralizes botulinum neurotoxin A by blocking host receptor binding
journal, August 2017


Crystal structure of botulinum neurotoxin type A and implications for toxicity
journal, October 1998

  • Lacy, D. Borden; Tepp, William; Cohen, Alona C.
  • Nature Structural Biology, Vol. 5, Issue 10
  • DOI: 10.1038/2338

Structural predictions of the channel-forming region of botulinum neurotoxin heavy chain
journal, April 1995


Structure and function of a unique pore-forming protein from a pathogenic acanthamoeba
journal, November 2012

  • Michalek, Matthias; Sönnichsen, Frank D.; Wechselberger, Rainer
  • Nature Chemical Biology, Vol. 9, Issue 1
  • DOI: 10.1038/nchembio.1116

Molecular Characterization of a Novel Botulinum Neurotoxin Type H Gene
journal, October 2013

  • Dover, Nir; Barash, Jason R.; Hill, Karen K.
  • The Journal of Infectious Diseases, Vol. 209, Issue 2
  • DOI: 10.1093/infdis/jit450

Comparison of the pH-induced conformational change of different clostridial neurotoxins
journal, June 2004

  • Puhar, A.; Johnson, E. A.; Rossetto, O.
  • Biochemical and Biophysical Research Communications, Vol. 319, Issue 1
  • DOI: 10.1016/j.bbrc.2004.04.140

MolProbity : all-atom structure validation for macromolecular crystallography
journal, December 2009

  • Chen, Vincent B.; Arendall, W. Bryan; Headd, Jeffrey J.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 1
  • DOI: 10.1107/S0907444909042073

Features and development of Coot
journal, March 2010

  • Emsley, P.; Lohkamp, B.; Scott, W. G.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 4
  • DOI: 10.1107/S0907444910007493

Structure of dual receptor binding to botulinum neurotoxin B
journal, June 2013

  • Berntsson, Ronnie P-A.; Peng, Lisheng; Dong, Min
  • Nature Communications, Vol. 4, Issue 1
  • DOI: 10.1038/ncomms3058

Translocation of botulinum neurotoxin light chain protease through the heavy chain channel
journal, December 2002

  • Koriazova, Lilia K.; Montal, Mauricio
  • Nature Structural Biology, Vol. 10, Issue 1
  • DOI: 10.1038/nsb879

On Botulinum Neurotoxin Variability
journal, January 2015


Botulinum and Tetanus Neurotoxins
journal, June 2019


The Novel Clostridial Neurotoxin Produced by Strain IBCA10-7060 Is Immunologically Equivalent to BoNT/HA
journal, December 2019


Single domain antibodies: promising experimental and therapeutic tools in infection and immunity
journal, June 2009

  • Wesolowski, Janusz; Alzogaray, Vanina; Reyelt, Jan
  • Medical Microbiology and Immunology, Vol. 198, Issue 3
  • DOI: 10.1007/s00430-009-0116-7

PHENIX: a comprehensive Python-based system for macromolecular structure solution
journal, January 2010

  • Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221
  • DOI: 10.1107/S0907444909052925

An Atypical Outbreak of Food-Borne Botulism Due to Clostridium botulinum Types B and E from Ham
journal, November 2014

  • Mazuet, Christelle; Sautereau, Jean; Legeay, Christine
  • Journal of Clinical Microbiology, Vol. 53, Issue 2
  • DOI: 10.1128/JCM.02942-14

On the translocation of botulinum and tetanus neurotoxins across the membrane of acidic intracellular compartments
journal, March 2016

  • Pirazzini, Marco; Tehran, Domenico Azarnia; Leka, Oneda
  • Biochimica et Biophysica Acta (BBA) - Biomembranes, Vol. 1858, Issue 3
  • DOI: 10.1016/j.bbamem.2015.08.014

Botulinum Toxin as a Biological Weapon: Medical and Public Health Management
journal, February 2001


Bioinformatic discovery of a toxin family in Chryseobacterium piperi with sequence similarity to botulinum neurotoxins
journal, February 2019


Studies of the Mechanistic Details of the pH-dependent Association of Botulinum Neurotoxin with Membranes
journal, June 2011

  • Mushrush, Darren J.; Koteiche, Hanane A.; Sammons, Morgan A.
  • Journal of Biological Chemistry, Vol. 286, Issue 30
  • DOI: 10.1074/jbc.M111.256982

Botulinum Neurotoxin Devoid of Receptor Binding Domain Translocates Active Protease
journal, December 2008


Two Cases of Type E Infant Botulism Caused by Neurotoxigenic Clostridium butyricum in Italy
journal, August 1986


N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A
journal, June 2016

  • Yao, Guorui; Zhang, Sicai; Mahrhold, Stefan
  • Nature Structural & Molecular Biology, Vol. 23, Issue 7
  • DOI: 10.1038/nsmb.3245

A viral-fusion-peptide-like molecular switch drives membrane insertion of botulinum neurotoxin A1
journal, December 2018


Free R value: a novel statistical quantity for assessing the accuracy of crystal structures
journal, January 1992


Camelid VHH Antibodies that Neutralize Botulinum Neurotoxin Serotype E Intoxication or Protease Function
journal, September 2020

  • Tremblay, Jacqueline M.; Vazquez-Cintron, Edwin; Lam, Kwok-Ho
  • Toxins, Vol. 12, Issue 10
  • DOI: 10.3390/toxins12100611

Experimentally determined hydrophobicity scale for proteins at membrane interfaces
journal, October 1996

  • Wimley, William C.; White, Stephen H.
  • Nature Structural & Molecular Biology, Vol. 3, Issue 10
  • DOI: 10.1038/nsb1096-842

Type E botulism
journal, November 2010


The Expanding Therapeutic Utility of Botulinum Neurotoxins
journal, May 2018


Mode of VAMP substrate recognition and inhibition of Clostridium botulinum neurotoxin F
journal, June 2009

  • Agarwal, Rakhi; Schmidt, James J.; Stafford, Robert G.
  • Nature Structural & Molecular Biology, Vol. 16, Issue 7
  • DOI: 10.1038/nsmb.1626

Beltless Translocation Domain of Botulinum Neurotoxin A Embodies a Minimum Ion-conductive Channel
journal, December 2011

  • Fischer, Audrey; Sambashivan, Shilpa; Brunger, Axel T.
  • Journal of Biological Chemistry, Vol. 287, Issue 3
  • DOI: 10.1074/jbc.C111.319400

Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin
journal, December 2010

  • Garcia-Rodriguez, C.; Geren, I. N.; Lou, J.
  • Protein Engineering Design and Selection, Vol. 24, Issue 3
  • DOI: 10.1093/protein/gzq111

Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity
journal, December 2006

  • Jin, Rongsheng; Rummel, Andreas; Binz, Thomas
  • Nature, Vol. 444, Issue 7122
  • DOI: 10.1038/nature05387

Phaser crystallographic software
journal, July 2007

  • McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.
  • Journal of Applied Crystallography, Vol. 40, Issue 4
  • DOI: 10.1107/S0021889807021206

Substrate recognition strategy for botulinum neurotoxin serotype A
journal, December 2004